Basics Monte Rosa Therapeutics, Inc. IPO Date: June 24, 2021 Sector: Healthcare Industry: Biotech Market Cap: $609.56M Activated in VL: True Average Daily Range Avg Daily Range: $0.39 | 4.17% Avg Daily Range (30 D): $0.32 | 4.14% Avg Daily Range (90 D): $0.20 | 3.20% Institutional Daily Volume Avg Daily Volume: .38M Avg Daily Volume (30 D): 1.82M Avg Daily Volume (90 D): .85M Trade Size Avg Trade Size (Sh.): 89 Avg Trade Size (Sh.) (30 D): 97 Avg Trade Size (Sh.) (90 D): 88 Institutional Trades Total Inst.Trades: 255 Avg Inst. Trade: $2.63M Avg Inst. Trade (30 D): $1.89M Avg Inst. Trade (90 D): $1.73M Avg Inst. Trade Volume: .28M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.5M Avg Closing Trade (30 D): $.8M Avg Closing Trade (90 D): $.85M Avg Closing Volume: 226.48K     News Sep 15, 2025 @ 3:29 PM Monte Rosa, Novartis Use AI-Powered Engine To Adva... Source: Vandana Singh Sep 15, 2025 @ 11:00 AM Monte Rosa Therapeutics Announces Collaboration wi... Source: Monte Rosa Therapeutics Jul 21, 2025 @ 11:00 AM Monte Rosa Therapeutics Announces First Subjects D... Source: Monte Rosa Therapeutics Jul 3, 2025 @ 6:15 PM Monte Rosa Announces Publication in Science of Key... Source: Monte Rosa Therapeutics Jun 10, 2025 @ 11:00 AM Monte Rosa Therapeutics Announces FDA Clearance of... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS Diluted EPS Revenue $ 177.99M $ 23.19M $ 84.93M Gross Profit $ $ $ Net Income / Loss $ 24.17M $ -12.3M $ 46.89M Operating Income / Loss $ 14.96M $ -15.55M $ 44.04M Cost of Revenue $ $ $ Net Cash Flow $ -39.33M $ -9.03M $ -145.71M PE Ratio